Methods for treating chemoresistant cancer-initiating cells
US11173173B2 · kind B2 · utility
1Cited by
0References
12Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Jul 28, 2016 |
| Grant date | Nov 16, 2021 |
| Priority date | — |
| Expiry date | Jan 20, 2037 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K9/0009
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The disclosure provides methods of treating cancer by selectively inhibiting p-S552-β-catenin, p-T217-β-catenin, p-T332-β-catenin, and/or p-S675-β-catenin production and/or activity. Such methods also and/or limit cancer-initiating cells.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.